Proteomics

Dataset Information

Whole proteome time course experiment in SJSA-1 cells


ABSTRACT: Navtemadlin is a potent small moeclule inhibitor of the p53-MDM2 protein-protein interaction, that is being tested in Phase II/III clinical trials for the treatment of cancer. In this experiment, we test the effect of Navtemadlin treatment on protein expression in SJSA-1 cells over the course of 24 h.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Amrita Date  

LAB HEAD: Anna Barnard

PROVIDER: PXD058053 | Pride | 2025-04-28

REPOSITORIES: Pride